According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Synthetic Blood Substitutes and Blood Product Market

Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient's immediate blood supply needs and to extend his or her life.

The global Synthetic Blood Substitutes and Blood Product market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Synthetic Blood Substitutes and Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Blood Substitutes and Blood Product.

Report Scope

The Synthetic Blood Substitutes and Blood Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Synthetic Blood Substitutes and Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Synthetic Blood Substitutes and Blood Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Synthetic Blood Substitutes and Blood Product Market Report

Report Metric	Details
Report Name	Synthetic Blood Substitutes and Blood Product Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Human Blood Animal Blood Microorganisms Synthetic Polymers Stem Cells Others
Segment by Application	Hospitals and Clinics Blood Banks Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Aurum Biosciences Ltd, Hemarina SA, KaloCyte Inc., NuvOx Pharma LLC, Northfield Laboratories, Dentritech, Inc., HemoBioTech, Inc., Dextro-Sang Corp., Baxter International, FluorO2 Therapeutics, Alpha Therapeutic Corp., Hemoglobin Oxygen Therapeutics LLC, SpheriTech Ltd, Sangart, Inc., BioPure, PHORNANO Holding GmbH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Synthetic Blood Substitutes and Blood Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Synthetic Blood Substitutes and Blood Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Synthetic Blood Substitutes and Blood Product Market report?

Ans: The main players in the Synthetic Blood Substitutes and Blood Product Market are Aurum Biosciences Ltd, Hemarina SA, KaloCyte Inc., NuvOx Pharma LLC, Northfield Laboratories, Dentritech, Inc., HemoBioTech, Inc., Dextro-Sang Corp., Baxter International, FluorO2 Therapeutics, Alpha Therapeutic Corp., Hemoglobin Oxygen Therapeutics LLC, SpheriTech Ltd, Sangart, Inc., BioPure, PHORNANO Holding GmbH

What are the Application segmentation covered in the Synthetic Blood Substitutes and Blood Product Market report?

Ans: The Applications covered in the Synthetic Blood Substitutes and Blood Product Market report are Hospitals and Clinics, Blood Banks, Others

What are the Type segmentation covered in the Synthetic Blood Substitutes and Blood Product Market report?

Ans: The Types covered in the Synthetic Blood Substitutes and Blood Product Market report are Human Blood, Animal Blood, Microorganisms, Synthetic Polymers, Stem Cells, Others

1 Synthetic Blood Substitutes and Blood Product Market Overview

1.1 Product Overview and Scope of Synthetic Blood Substitutes and Blood Product

1.2 Synthetic Blood Substitutes and Blood Product Segment by Type

1.2.1 Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024-2030)

1.2.2 Human Blood

1.2.3 Animal Blood

1.2.4 Microorganisms

1.2.5 Synthetic Polymers

1.2.6 Stem Cells

1.2.7 Others

1.3 Synthetic Blood Substitutes and Blood Product Segment by Application

1.3.1 Global Synthetic Blood Substitutes and Blood Product Market Value by Application: (2024-2030)

1.3.2 Hospitals and Clinics

1.3.3 Blood Banks

1.3.4 Others

1.4 Global Synthetic Blood Substitutes and Blood Product Market Size Estimates and Forecasts

1.4.1 Global Synthetic Blood Substitutes and Blood Product Revenue 2019-2030

1.4.2 Global Synthetic Blood Substitutes and Blood Product Sales 2019-2030

1.4.3 Global Synthetic Blood Substitutes and Blood Product Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Synthetic Blood Substitutes and Blood Product Market Competition by Manufacturers

2.1 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2019-2024)

2.2 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Synthetic Blood Substitutes and Blood Product Average Price by Manufacturers (2019-2024)

2.4 Global Synthetic Blood Substitutes and Blood Product Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application

2.7 Synthetic Blood Substitutes and Blood Product Market Competitive Situation and Trends

2.7.1 Synthetic Blood Substitutes and Blood Product Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Synthetic Blood Substitutes and Blood Product Players Market Share by Revenue

2.7.3 Global Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Synthetic Blood Substitutes and Blood Product Retrospective Market Scenario by Region

3.1 Global Synthetic Blood Substitutes and Blood Product Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Synthetic Blood Substitutes and Blood Product Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2019-2030

3.2.1 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2019-2024

3.2.2 Global Synthetic Blood Substitutes and Blood Product Sales by Region: 2025-2030

3.3 Global Synthetic Blood Substitutes and Blood Product Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2019-2030

3.3.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2019-2024

3.3.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Region: 2025-2030

3.4 North America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country

3.4.1 North America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2030)

3.4.3 North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country

3.5.1 Europe Synthetic Blood Substitutes and Blood Product Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2030)

3.5.3 Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country

3.6.1 Asia Pacific Synthetic Blood Substitutes and Blood Product Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2030)

3.6.3 Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country

3.7.1 Latin America Synthetic Blood Substitutes and Blood Product Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2030)

3.7.3 Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Facts & Figures by Country

3.8.1 Middle East and Africa Synthetic Blood Substitutes and Blood Product Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2030)

3.8.3 Middle East and Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2019-2030)

4.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2019-2024)

4.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Type (2025-2030)

4.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2019-2030)

4.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2019-2030)

4.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2019-2024)

4.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Type (2025-2030)

4.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2019-2030)

4.3 Global Synthetic Blood Substitutes and Blood Product Price by Type (2019-2030)

5 Segment by Application

5.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2019-2030)

5.1.1 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2019-2024)

5.1.2 Global Synthetic Blood Substitutes and Blood Product Sales by Application (2025-2030)

5.1.3 Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2019-2030)

5.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2019-2030)

5.2.1 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2019-2024)

5.2.2 Global Synthetic Blood Substitutes and Blood Product Revenue by Application (2025-2030)

5.2.3 Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2019-2030)

5.3 Global Synthetic Blood Substitutes and Blood Product Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Aurum Biosciences Ltd

6.1.1 Aurum Biosciences Ltd Corporation Information

6.1.2 Aurum Biosciences Ltd Description and Business Overview

6.1.3 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio

6.1.5 Aurum Biosciences Ltd Recent Developments/Updates

6.2 Hemarina SA

6.2.1 Hemarina SA Corporation Information

6.2.2 Hemarina SA Description and Business Overview

6.2.3 Hemarina SA Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Hemarina SA Synthetic Blood Substitutes and Blood Product Product Portfolio

6.2.5 Hemarina SA Recent Developments/Updates

6.3 KaloCyte Inc.

6.3.1 KaloCyte Inc. Corporation Information

6.3.2 KaloCyte Inc. Description and Business Overview

6.3.3 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.3.4 KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.3.5 KaloCyte Inc. Recent Developments/Updates

6.4 NuvOx Pharma LLC

6.4.1 NuvOx Pharma LLC Corporation Information

6.4.2 NuvOx Pharma LLC Description and Business Overview

6.4.3 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.4.4 NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product Portfolio

6.4.5 NuvOx Pharma LLC Recent Developments/Updates

6.5 Northfield Laboratories

6.5.1 Northfield Laboratories Corporation Information

6.5.2 Northfield Laboratories Description and Business Overview

6.5.3 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product Portfolio

6.5.5 Northfield Laboratories Recent Developments/Updates

6.6 Dentritech, Inc.

6.6.1 Dentritech, Inc. Corporation Information

6.6.2 Dentritech, Inc. Description and Business Overview

6.6.3 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.6.5 Dentritech, Inc. Recent Developments/Updates

6.7 HemoBioTech, Inc.

6.6.1 HemoBioTech, Inc. Corporation Information

6.6.2 HemoBioTech, Inc. Description and Business Overview

6.6.3 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.4.4 HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.7.5 HemoBioTech, Inc. Recent Developments/Updates

6.8 Dextro-Sang Corp.

6.8.1 Dextro-Sang Corp. Corporation Information

6.8.2 Dextro-Sang Corp. Description and Business Overview

6.8.3 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.8.5 Dextro-Sang Corp. Recent Developments/Updates

6.9 Baxter International

6.9.1 Baxter International Corporation Information

6.9.2 Baxter International Description and Business Overview

6.9.3 Baxter International Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Baxter International Synthetic Blood Substitutes and Blood Product Product Portfolio

6.9.5 Baxter International Recent Developments/Updates

6.10 FluorO2 Therapeutics

6.10.1 FluorO2 Therapeutics Corporation Information

6.10.2 FluorO2 Therapeutics Description and Business Overview

6.10.3 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.10.4 FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product Portfolio

6.10.5 FluorO2 Therapeutics Recent Developments/Updates

6.11 Alpha Therapeutic Corp.

6.11.1 Alpha Therapeutic Corp. Corporation Information

6.11.2 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.11.3 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.11.5 Alpha Therapeutic Corp. Recent Developments/Updates

6.12 Hemoglobin Oxygen Therapeutics LLC

6.12.1 Hemoglobin Oxygen Therapeutics LLC Corporation Information

6.12.2 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.12.3 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product Portfolio

6.12.5 Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates

6.13 SpheriTech Ltd

6.13.1 SpheriTech Ltd Corporation Information

6.13.2 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.13.3 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.13.4 SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product Portfolio

6.13.5 SpheriTech Ltd Recent Developments/Updates

6.14 Sangart, Inc.

6.14.1 Sangart, Inc. Corporation Information

6.14.2 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.14.3 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product Portfolio

6.14.5 Sangart, Inc. Recent Developments/Updates

6.15 BioPure

6.15.1 BioPure Corporation Information

6.15.2 BioPure Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.15.3 BioPure Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.15.4 BioPure Synthetic Blood Substitutes and Blood Product Product Portfolio

6.15.5 BioPure Recent Developments/Updates

6.16 PHORNANO Holding GmbH

6.16.1 PHORNANO Holding GmbH Corporation Information

6.16.2 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Description and Business Overview

6.16.3 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales, Revenue and Gross Margin (2019-2024)

6.16.4 PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product Portfolio

6.16.5 PHORNANO Holding GmbH Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Synthetic Blood Substitutes and Blood Product Industry Chain Analysis

7.2 Synthetic Blood Substitutes and Blood Product Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Synthetic Blood Substitutes and Blood Product Production Mode & Process

7.4 Synthetic Blood Substitutes and Blood Product Sales and Marketing

7.4.1 Synthetic Blood Substitutes and Blood Product Sales Channels

7.4.2 Synthetic Blood Substitutes and Blood Product Distributors

7.5 Synthetic Blood Substitutes and Blood Product Customers

8 Synthetic Blood Substitutes and Blood Product Market Dynamics

8.1 Synthetic Blood Substitutes and Blood Product Industry Trends

8.2 Synthetic Blood Substitutes and Blood Product Market Drivers

8.3 Synthetic Blood Substitutes and Blood Product Market Challenges

8.4 Synthetic Blood Substitutes and Blood Product Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Aurum Biosciences Ltd.

HEMARINA SA

KaloCyte Inc.

NuvOx Pharma LLC

Northfield Laboratories

Alpha Therapeutic Corp

Hemoglobin Oxygen Therapeutics LLC

SpheriTech Ltd.

Sangart

BioPure

PHORNANO Holding GmbH

List of Tables

Table 1. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Synthetic Blood Substitutes and Blood Product Market Competitive Situation by Manufacturers in 2023

Table 4. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Synthetic Blood Substitutes and Blood Product, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Product Type & Application

Table 12. Global Key Manufacturers of Synthetic Blood Substitutes and Blood Product, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Synthetic Blood Substitutes and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Blood Substitutes and Blood Product as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2019-2024) & (K Units)

Table 18. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2019-2024)

Table 19. Global Synthetic Blood Substitutes and Blood Product Sales by Region (2025-2030) & (K Units)

Table 20. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2025-2030)

Table 21. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2019-2024)

Table 23. Global Synthetic Blood Substitutes and Blood Product Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2025-2030)

Table 25. North America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2024) & (K Units)

Table 27. North America Synthetic Blood Substitutes and Blood Product Sales by Country (2025-2030) & (K Units)

Table 28. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Synthetic Blood Substitutes and Blood Product Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2024) & (K Units)

Table 32. Europe Synthetic Blood Substitutes and Blood Product Sales by Country (2025-2030) & (K Units)

Table 33. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Synthetic Blood Substitutes and Blood Product Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Synthetic Blood Substitutes and Blood Product Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Synthetic Blood Substitutes and Blood Product Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Synthetic Blood Substitutes and Blood Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Synthetic Blood Substitutes and Blood Product Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2019-2024)

Table 51. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Type (2025-2030)

Table 52. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2019-2024)

Table 53. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Type (2025-2030)

Table 54. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2019-2024)

Table 57. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Type (2025-2030)

Table 58. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2019-2024)

Table 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2025-2030)

Table 60. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2019-2024)

Table 61. Global Synthetic Blood Substitutes and Blood Product Sales (K Units) by Application (2025-2030)

Table 62. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2019-2024)

Table 63. Global Synthetic Blood Substitutes and Blood Product Sales Market Share by Application (2025-2030)

Table 64. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Synthetic Blood Substitutes and Blood Product Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2019-2024)

Table 67. Global Synthetic Blood Substitutes and Blood Product Revenue Market Share by Application (2025-2030)

Table 68. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2019-2024)

Table 69. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2025-2030)

Table 70. Aurum Biosciences Ltd Corporation Information

Table 71. Aurum Biosciences Ltd Description and Business Overview

Table 72. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Aurum Biosciences Ltd Synthetic Blood Substitutes and Blood Product Product

Table 74. Aurum Biosciences Ltd Recent Developments/Updates

Table 75. Hemarina SA Corporation Information

Table 76. Hemarina SA Description and Business Overview

Table 77. Hemarina SA Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Hemarina SA Synthetic Blood Substitutes and Blood Product Product

Table 79. Hemarina SA Recent Developments/Updates

Table 80. KaloCyte Inc. Corporation Information

Table 81. KaloCyte Inc. Description and Business Overview

Table 82. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. KaloCyte Inc. Synthetic Blood Substitutes and Blood Product Product

Table 84. KaloCyte Inc. Recent Developments/Updates

Table 85. NuvOx Pharma LLC Corporation Information

Table 86. NuvOx Pharma LLC Description and Business Overview

Table 87. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. NuvOx Pharma LLC Synthetic Blood Substitutes and Blood Product Product

Table 89. NuvOx Pharma LLC Recent Developments/Updates

Table 90. Northfield Laboratories Corporation Information

Table 91. Northfield Laboratories Description and Business Overview

Table 92. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Northfield Laboratories Synthetic Blood Substitutes and Blood Product Product

Table 94. Northfield Laboratories Recent Developments/Updates

Table 95. Dentritech, Inc. Corporation Information

Table 96. Dentritech, Inc. Description and Business Overview

Table 97. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Dentritech, Inc. Synthetic Blood Substitutes and Blood Product Product

Table 99. Dentritech, Inc. Recent Developments/Updates

Table 100. HemoBioTech, Inc. Corporation Information

Table 101. HemoBioTech, Inc. Description and Business Overview

Table 102. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. HemoBioTech, Inc. Synthetic Blood Substitutes and Blood Product Product

Table 104. HemoBioTech, Inc. Recent Developments/Updates

Table 105. Dextro-Sang Corp. Corporation Information

Table 106. Dextro-Sang Corp. Description and Business Overview

Table 107. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Dextro-Sang Corp. Synthetic Blood Substitutes and Blood Product Product

Table 109. Dextro-Sang Corp. Recent Developments/Updates

Table 110. Baxter International Corporation Information

Table 111. Baxter International Description and Business Overview

Table 112. Baxter International Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Baxter International Synthetic Blood Substitutes and Blood Product Product

Table 114. Baxter International Recent Developments/Updates

Table 115. FluorO2 Therapeutics Corporation Information

Table 116. FluorO2 Therapeutics Description and Business Overview

Table 117. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. FluorO2 Therapeutics Synthetic Blood Substitutes and Blood Product Product

Table 119. FluorO2 Therapeutics Recent Developments/Updates

Table 120. Alpha Therapeutic Corp. Corporation Information

Table 121. Alpha Therapeutic Corp. Description and Business Overview

Table 122. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Alpha Therapeutic Corp. Synthetic Blood Substitutes and Blood Product Product

Table 124. Alpha Therapeutic Corp. Recent Developments/Updates

Table 125. Hemoglobin Oxygen Therapeutics LLC Corporation Information

Table 126. Hemoglobin Oxygen Therapeutics LLC Description and Business Overview

Table 127. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Hemoglobin Oxygen Therapeutics LLC Synthetic Blood Substitutes and Blood Product Product

Table 129. Hemoglobin Oxygen Therapeutics LLC Recent Developments/Updates

Table 130. SpheriTech Ltd Corporation Information

Table 131. SpheriTech Ltd Description and Business Overview

Table 132. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. SpheriTech Ltd Synthetic Blood Substitutes and Blood Product Product

Table 134. SpheriTech Ltd Recent Developments/Updates

Table 135. Sangart, Inc. Corporation Information

Table 136. Sangart, Inc. Description and Business Overview

Table 137. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Sangart, Inc. Synthetic Blood Substitutes and Blood Product Product

Table 139. Sangart, Inc. Recent Developments/Updates

Table 140. BioPure Corporation Information

Table 141. BioPure Description and Business Overview

Table 142. BioPure Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. BioPure Synthetic Blood Substitutes and Blood Product Product

Table 144. BioPure Recent Developments/Updates

Table 145. PHORNANO Holding GmbH Corporation Information

Table 146. PHORNANO Holding GmbH Description and Business Overview

Table 147. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. PHORNANO Holding GmbH Synthetic Blood Substitutes and Blood Product Product

Table 149. PHORNANO Holding GmbH Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Synthetic Blood Substitutes and Blood Product Distributors List

Table 153. Synthetic Blood Substitutes and Blood Product Customers List

Table 154. Synthetic Blood Substitutes and Blood Product Market Trends

Table 155. Synthetic Blood Substitutes and Blood Product Market Drivers

Table 156. Synthetic Blood Substitutes and Blood Product Market Challenges

Table 157. Synthetic Blood Substitutes and Blood Product Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Synthetic Blood Substitutes and Blood Product

Figure 2. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Synthetic Blood Substitutes and Blood Product Market Share by Type in 2023 & 2030

Figure 4. Human Blood Product Picture

Figure 5. Animal Blood Product Picture

Figure 6. Microorganisms Product Picture

Figure 7. Synthetic Polymers Product Picture

Figure 8. Stem Cells Product Picture

Figure 9. Others Product Picture

Figure 10. Global Synthetic Blood Substitutes and Blood Product Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Synthetic Blood Substitutes and Blood Product Market Share by Application in 2023 & 2030

Figure 12. Hospitals and Clinics

Figure 13. Blood Banks

Figure 14. Others

Figure 15. Global Synthetic Blood Substitutes and Blood Product Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Synthetic Blood Substitutes and Blood Product Market Size (2019-2030) & (US$ Million)

Figure 17. Global Synthetic Blood Substitutes and Blood Product Sales (2019-2030) & (K Units)

Figure 18. Global Synthetic Blood Substitutes and Blood Product Average Price (US$/Unit) & (2019-2030)

Figure 19. Synthetic Blood Substitutes and Blood Product Report Years Considered

Figure 20. Synthetic Blood Substitutes and Blood Product Sales Share by Manufacturers in 2023

Figure 21. Global Synthetic Blood Substitutes and Blood Product Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Synthetic Blood Substitutes and Blood Product Players: Market Share by Revenue in 2023

Figure 23. Synthetic Blood Substitutes and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Synthetic Blood Substitutes and Blood Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2019-2030)

Figure 26. North America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2019-2030)

Figure 27. United States Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2019-2030)

Figure 30. Europe Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2019-2030)

Figure 31. Germany Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Synthetic Blood Substitutes and Blood Product Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Synthetic Blood Substitutes and Blood Product Revenue Market Share by Region (2019-2030)

Figure 38. China Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. China Taiwan Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2019-2030)

Figure 48. Latin America Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Synthetic Blood Substitutes and Blood Product Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Synthetic Blood Substitutes and Blood Product Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Synthetic Blood Substitutes and Blood Product Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Type (2019-2030)

Figure 58. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Type (2019-2030)

Figure 59. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Synthetic Blood Substitutes and Blood Product by Application (2019-2030)

Figure 61. Global Revenue Market Share of Synthetic Blood Substitutes and Blood Product by Application (2019-2030)

Figure 62. Global Synthetic Blood Substitutes and Blood Product Price (US$/Unit) by Application (2019-2030)

Figure 63. Synthetic Blood Substitutes and Blood Product Value Chain

Figure 64. Synthetic Blood Substitutes and Blood Product Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Asset Management Software Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7H15710

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Drug Interactions Checker Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12A14387

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Elderly Care Service Certification Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0W16001

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

Global Androgen Antagonist Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24N12667

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions